CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 151 enrolled
Drug / intervention
florbetapir F 18drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01550549
NCT01550549N/ACompleted
CompareCT.gov

Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans

Avid Radiopharmaceuticals·interventional·Posted Mar 12, 2012·Updated Jun 7, 2012

In Brief

A clinical study evaluating florbetapir F 18 for Alzheimer Disease and 2 related conditions. Completed, enrolled 151 participants.

Detailed Summary

This study will investigate the performance of physician readers trained to read florbetapir-PET scans using electronic media training.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer Disease, Mild Cognitive Impairment, Neurodegenerative Diseases
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 12, 2012
Enrollment StartAug 1, 2011
Primary CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.3 years ago

Interventions

florbetapir F 18drug

No study drug will be administered in this study - scans previously acquired in in Study A05(NCT00702143) and A07(NCT00857415) will be read